|
|
Post by lennymnkd on Mar 8, 2024 9:42:09 GMT -5
Hey I still have my AFREZZA inhaler still wrapped in plastic from that meeting 👍
|
|
|
|
Post by sayhey24 on Mar 8, 2024 9:44:06 GMT -5
Hey I still have my AFREZZA inhaler still wrapped in plastic from that meeting 👍 I use my Mannkind soft cooler at the beach all the time. |
|
|
|
Post by sr71 on Mar 8, 2024 9:48:03 GMT -5
According to the newsletter, this year's shareholder meeting is "Virtual". |
|
|
|
Post by prcgorman2 on Mar 8, 2024 11:08:39 GMT -5
According to the newsletter, this year's shareholder meeting is "Virtual". It's cheaper. |
|
|
|
Post by sayhey24 on Mar 8, 2024 11:20:48 GMT -5
Well that really sucks if its only virtual. If thats the case it raises the question why doesn't he want to face the shareholders.
|
|
|
|
Post by jkendra on Mar 8, 2024 11:34:57 GMT -5
Personally I’m glad a lot of the irrational bozos on here aren’t able to attend in person. 😀
|
|
|
|
Post by sayhey24 on Mar 8, 2024 12:27:25 GMT -5
Personally I’m glad a lot of the irrational bozos on here aren’t able to attend in person. 😀 Hey man, give Mike a break. He is the CEO and should be able to attend even if he invited Damon Dash and Jeffrey Dachis for the clown show the last time. I will say One Drop has sure pivoted and are trying to make their own OTC CGM and have embraced GLP1s. |
|
|
|
Post by mytakeonit on Mar 8, 2024 12:48:57 GMT -5
Well that really sucks if its only virtual. If thats the case it raises the question why doesn't he want to face the shareholders. It's because $$$ is tight and he can't afford to give out those beach coolers now. But, that's mytakeonit |
|
|
|
Post by sayhey24 on Mar 8, 2024 12:56:18 GMT -5
Well that really sucks if its only virtual. If thats the case it raises the question why doesn't he want to face the shareholders. It's because $$$ is tight and he can't afford to give out those beach coolers now. But, that's mytakeonit Maybe we could find a buyer for V-Go. My beach cooler is faded and has a pin hold in the liner. I patched it up with flex seal paste but I could really use a new one. |
|
|
|
Post by jkendra on Mar 8, 2024 13:31:48 GMT -5
Personally I’m glad a lot of the irrational bozos on here aren’t able to attend in person. 😀 Hey man, give Mike a break. He is the CEO and should be able to attend even if he invited Damon Dash and Jeffrey Dachis for the clown show the last time. I will say One Drop has sure pivoted and are trying to make their own OTC CGM and have embraced GLP1s. Remember when Jeffrey got so irate anytime someone mentioned Afrezza he started convulsing and blocking people. He was a level headed, friendly partner. |
|
|
|
Post by jkendra on Mar 8, 2024 13:52:51 GMT -5
The best part about all of these meetings and conferences is going over the charts like below. Still sitting seemingly really undervalued at a $1.4B market cap.
|
|
|
|
Post by alethea on Mar 8, 2024 14:07:26 GMT -5
Those charts must be wrong. The resident "experts" have been swamping the Board for a long time that there really isn't any significant revenue growth. Per them, no real Afrezza growth at all. And Tyvaso DPI royalties have leveled off, are factored in and don't provide much prospect of raising the share price going forward. At least that's what we've been told. Ad nauseam.  |
|
|
|
Post by longliner on Mar 8, 2024 14:10:54 GMT -5
Those charts must be wrong. The resident "experts" have been swamping the Board for a long time that there really isn't any significant revenue growth. Per them, no real Afrezza growth at all. And Tyvaso DPI royalties have leveled off, are factored in and don't provide much prospect of raising the share price going forward. At least that's what we've been told. Ad nauseam. Please alethea, they like to be called realist's.  |
|
|
|
Post by ktim on Mar 8, 2024 14:51:15 GMT -5
Those charts must be wrong. The resident "experts" have been swamping the Board for a long time that there really isn't any significant revenue growth. Per them, no real Afrezza growth at all. And Tyvaso DPI royalties have leveled off, are factored in and don't provide much prospect of raising the share price going forward. At least that's what we've been told. Ad nauseam. Who on earth has been saying that? Granted there was the somewhat exaggerated Tyvaso royalty growth rate due to inventory build that then decelerated (not flattening revenue). That led to a bit of surprise/disappointment for some since the method of recognition wasn't fully appreciated earlier. But no one that I recall ever said Tyvaso DPI revenue had leveled off. I think you should really review these posts you think you remember. Should be easy to find, or not find, since you think it was swamping the board. I suspect your mind is playing tricks on you. I think being a long time investor in MNKD can cause symptoms similar to Long Covid... memory fog and such. |
|
|
|
Post by cretin11 on Mar 8, 2024 15:07:15 GMT -5
Well (and politely) said, ktim.
|
|
